Skip to content
Baret News – Lifestyle
Author:
NovaBridge Biosciences
NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
October 25, 2026
Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia
October 20, 2026
Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis
October 13, 2026
NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
October 8, 2026
NovaBridge Appoints Martin Dewhurst to Board as Independent Director
September 8, 2026
NovaBridge Biosciences to Participate in September Investor Conferences
August 27, 2026
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
August 20, 2026
NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026
August 13, 2026
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
July 24, 2026
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
June 29, 2026
1
2
Next Page
→